Influence of high homocysteine and low folate plasmatic levels in medium-term prognosis after acute coronary syndromes

International Journal of Cardiology

Volumn 118, Issue 2, 2007, Pages 220-226

  García Pinilla, José Manuel ^a   Espinosa Caliani, Salvador ^a   Gómez Doblas, Juan José ^a   Jiménez Navarro, Manuel ^a   Gaitán, María J ^b   Muñoz Morán, Encarnación ^b   Cabrera Bueno, Fernando ^a   Hernández García, José M ^a   Ortega Jiménez, María Victoria ^a   Ruiz Galdón, Maximiliano ^b   Reyes Engel, Armando ^b   de Teresa Galván, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Unit of Pharmacology   (Spain)

Author keywords

Acute coronary syndrome; Folate; Homocysteine

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HEART DEATH; HUMAN; HYPERHOMOCYSTEINEMIA; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; FOLIC ACID DEFICIENCY; FOLLOW-UP STUDIES; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 34247138830     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.053     Document Type: Article

References (43)

1. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 13 (1995) 1049-1057
2. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277 22 (1997) 1775-1781
3. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 4 (1997) 230-236
4. Stubbs P.J., Al Obaidi M.K., Conroy R.M., et al. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 102 6 (2000) 605-610
5. Facila L., Nunez J.E., VB G, et al. Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?. Int J Cardiol 100 2 (2005) 275-279
6. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56 1 (1969) 111-128
7. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 15 (1998) 1042-1050
8. Bescond A., Augier T., Chareyre C., Garcon D., Hornebeck W., and Charpiot P. Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun 263 2 (1999) 498-503
9. Durand P., Lussier-Cacan S., and Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11 13 (1997) 1157-1168
10. Dardik R., Varon D., Tamarin I., et al. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Thromb Haemost 83 2 (2000) 338-344
11. Al Obaidi M.K., Philippou H., Stubbs P.J., et al. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation 101 4 (2000) 372-377
12. Dudman N.P., Hicks C., Wang J., and Wilcken DE. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91 1-2 (1991) 77-83
13. Folsom A.R., Nieto F.J., McGovern P.G., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 98 3 (1998) 204-210
14. Voutilainen S., Lakka T.A., Porkkala-Sarataho E., Rissanen T., Kaplan G.A., and Salonen J.T. Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Eur J Clin Nutr 54 5 (2000) 424-428
15. Voutilainen S., Rissanen T.H., Virtanen J., Lakka T.A., and Salonen J.T. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103 22 (2001) 2674-2680
16. Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., and Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Lond) 96 3 (1999) 235-239
17. Cole D.E., Lehotay D.C., and Evrovski J. Simplified simultaneous assay of total plasma homocysteine and methionine by HPLC and pulsed integrated amperometry. Clin Chem 44 1 (1998) 188-190
18. Malinow M.R., Duell P.B., Hess D.L., et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338 15 (1998) 1009-1015
19. Neal B., MacMahon S., Ohkubo T., Tonkin A., and Wilcken D. Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. Eur Heart J 23 19 (2002) 1509-1515
20. Anderson J.L., Horne B.D., Carlquist J.F., et al. Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease. Am J Cardiol 90 5 (2002) 536-539
21. Willems F.F., Aengevaeren W.R., Boers G.H., Blom H.J., and Verheugt F.W. Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol 40 4 (2002) 766-772
22. Doshi S.N., McDowell I.F., Moat S.J., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 21 7 (2001) 1196-1202
23. Doshi S.N., McDowell I.F., Moat S.J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105 1 (2002) 22-26
24. de Bree A., Verschuren W.M., Blom H.J., Nadeau M., Trijbels F.J., and Kromhout D. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis 166 2 (2003) 369-377
25. Giles W.H., Kittner S.J., Croft J.B., Anda R.F., Casper M.L., and Ford E.S. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Ann Epidemiol 8 8 (1998) 490-496
26. Voutilainen S., Virtanen J.K., Rissanen T.H., et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 80 2 (2004) 317-323
27. Chasan-Taber L., Selhub J., Rosenberg I.H., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 15 2 (1996) 136-143
28. Hung J., Beilby J.P., Knuiman M.W., and Divitini M. Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. BMJ 326 7381 (2003) 131
29. Schnyder G., Roffi M., Flammer Y., Pin R., and Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart Study: a randomized controlled trial. JAMA 288 8 (2002) 973-979
30. Liem A., Reynierse-Buitenwerf G.H., Zwinderman A.H., Jukema J.W., and van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 41 12 (2003) 2105-2113
31. Liem A.H., van Boven A.J., Veeger N.J., et al. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 93 2-3 (2004) 175-179
32. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 15 (2006) 1578-1588
33. Lonn E., Yusuf S., Arnold M.J., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 15 (2006) 1567-1577
34. Brilakis E.S., Berger P.B., Ballman K.V., and Rozen R. Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis 168 2 (2003) 315-322
35. Danesh J., and Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 5 4 (1998) 229-232
36. Brattstrom L., and Wilcken D.E. Homocysteine and cardiovascular disease: cause or effect?. Am J Clin Nutr 72 2 (2000) 315-323
37. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 16 (2002) 2015-2022
38. Soinio M., Marniemi J., Laakso M., Lehto S., and Ronnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 140 2 (2004) 94-100
39. Matetzky S., Freimark D., Ben Ami S., et al. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction. Arch Intern Med 163 16 (2003) 1933-1937
40. Omland T., Samuelsson A., Hartford M., et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160 12 (2000) 1834-1840
41. Evans R.W., Shaten B.J., Hempel J.D., Cutler J.A., and Kuller L.H. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 17 10 (1997) 1947-1953
42. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 16 (2002) 2023-2031
43. Aronow W.S. Homocysteine. The association with atherosclerotic vascular disease in older persons. Geriatrics 58 9 (2003) 22-28